C. Jillian Tsai, Lead of Palliative Radiotherapy and Oligometastases Program (PROP) at Princess Margaret Cancer Centre, posted on X:
“Remarkable efforts to obtain on-treatment tissue to study TME.
CRT with sequential pembro *might* be more favorable than concurrent pembro.”
Ttile: Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer
Authors: Dan P. Zandberg, Lazar Vujanovic, David A. Clump, Brian P. Isett, Hong Wang, Gabriel Sica, Riyue Bao, Housayin Li, James Ohr, Heath D. Skinner, Raja R. Seethala, Simion I. Chiosea, Robert L. Ferris, Julie E. Bauman
Read The Full Article at Journal of Clinical Oncology.
More posts featuring Head and Neck Cancer.